Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/7408
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
Metadata
Show full item record
VACCINATION WITH THE LEISHMANIA MAJOR RIBOSOMAL PROTEINS PLUS CPG OLIGODEOXYNUCLEOTIDES INDUCES PROTECTION AGAINST EXPERIMENTAL CUTANEOUS LEISHMANIASIS IN MICE
Vacinas contra Leishmaniose
Leishmaniose Cutânea/prevenção & controle
Oligodesoxirribonucleotídeos/imunologia
Proteínas Ribossômicas/imunologia
Animais
Feminino
Imunoglobulina G/metabolismo
Interferon gama/metabolismo
Interleucina-10/metabolismo
Interleucina-4/metabolismo
Leishmaniose Cutânea/imunologia
Camundongos
Camundongos Endogâmicos BALB C
Camundongos Endogâmicos C57BL
Oligodesoxirribonucleotídeos/genética
Oligodesoxirribonucleotídeos/metabolismo
Proteínas de Protozoários/genética
Proteínas de Protozoários/imunologia
Proteínas de Protozoários/metabolismo
Proteínas Ribossômicas/genética
Proteínas Ribossômicas/metabolismo
Author
Affilliation
Instituto de Salud Carlos III. Centro Nacional de Microbiología. Unidad de Inmunología Viral. Majadahonda, Madrid, Spain
Universidad Autónoma de Madrid. Facultad de Ciencias. Centro de Biología Molecular Severo Ochoa. Departamento de Biología Molecular. Madrid, Spain
Universidad Autónoma de Madrid. Facultad de Ciencias. Centro de Biología Molecular Severo Ochoa. Departamento de Biología Molecular. Madrid, Spain
Universidad Autónoma de Madrid. Facultad de Ciencias. Centro de Biología Molecular Severo Ochoa. Departamento de Biología Molecular. Madrid, Spain
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil
Universidad Autónoma de Madrid. Facultad de Ciencias. Centro de Biología Molecular Severo Ochoa. Departamento de Biología Molecular. Madrid, Spain
Universidad Autónoma de Madrid. Facultad de Ciencias. Centro de Biología Molecular Severo Ochoa. Departamento de Biología Molecular. Madrid, Spain
Universidad Autónoma de Madrid. Facultad de Ciencias. Centro de Biología Molecular Severo Ochoa. Departamento de Biología Molecular. Madrid, Spain
Universidad Autónoma de Madrid. Facultad de Ciencias. Centro de Biología Molecular Severo Ochoa. Departamento de Biología Molecular. Madrid, Spain
Universidad Autónoma de Madrid. Facultad de Ciencias. Centro de Biología Molecular Severo Ochoa. Departamento de Biología Molecular. Madrid, Spain
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil
Universidad Autónoma de Madrid. Facultad de Ciencias. Centro de Biología Molecular Severo Ochoa. Departamento de Biología Molecular. Madrid, Spain
Universidad Autónoma de Madrid. Facultad de Ciencias. Centro de Biología Molecular Severo Ochoa. Departamento de Biología Molecular. Madrid, Spain
Abstract
In the present work we analyze the antigenicity of Leishmania major ribosomal proteins (LRP) in infected BALB/c mice.We show that BALB/c
mice vaccinated with LRP in the presence of CpG oligodeoxynucleotides (CpG-ODN) were protected against the development of dermal pathology
and showed a reduction in the parasite load after challenge with L. major. This protection was associated with the induction of an IL-12 dependent
specific-IFN-g response mediated mainly by CD4þ T cell, albeit a minor contribution of CD8þ T cells cannot be ruled out. Induction of Th1
responses against LRP also resulted in a reversion of the Th2 responses associated with susceptibility. A marked reduction of IgG1 antibody titer
against parasite antigens besides an impaired IL-4 and IL-10 cytokine production by parasite specific T cells was observed. In addition, we show
that the administration of the LRP plus CpG-ODN preparation also conferred protection in the naturally resistant C57BL/6 mice. In this strain
protection was associated with a LRP specific IFN-g production in lymph nodes draining the challenge site. We believe that these evolutionary
conserved proteins, combined with adjuvants that favor Th1 responses, may be relevant components of a pan-Leishmania vaccine.
2008 Elsevier Masson SAS. All rights reserved
DeCS
Leishmania major/imunologiaVacinas contra Leishmaniose
Leishmaniose Cutânea/prevenção & controle
Oligodesoxirribonucleotídeos/imunologia
Proteínas Ribossômicas/imunologia
Animais
Feminino
Imunoglobulina G/metabolismo
Interferon gama/metabolismo
Interleucina-10/metabolismo
Interleucina-4/metabolismo
Leishmaniose Cutânea/imunologia
Camundongos
Camundongos Endogâmicos BALB C
Camundongos Endogâmicos C57BL
Oligodesoxirribonucleotídeos/genética
Oligodesoxirribonucleotídeos/metabolismo
Proteínas de Protozoários/genética
Proteínas de Protozoários/imunologia
Proteínas de Protozoários/metabolismo
Proteínas Ribossômicas/genética
Proteínas Ribossômicas/metabolismo
Share